<DOC>
	<DOCNO>NCT01047150</DOCNO>
	<brief_summary>Research Questions : 1 . Is significant difference causal repeat rate myocardial perfusion study Tc99m tetrofosmin Tc99m sestamibi ? 2 . Is significant difference causal repeat rate myocardial perfusion study Tc99m tetrofosmin Tc99m sestamibi independent technologist reviewer blind radiopharmaceutical make decision repeat study ? 3 . Is significant difference quantitative diagnostic measure report original acceptable repeat study ?</brief_summary>
	<brief_title>The Comparison Necessity Repeat Myocardial Perfusion SPECT Studies Between Tc-99m Tetro Tc-99m Mibi</brief_title>
	<detailed_description>There two commonly use Tc-99m base radiopharmaceutical useful diagnosis localization region reversible myocardial ischemia presence absence infarction exercise rest condition . One Tc-99m tetrofosmin ( Tc-99m-1,2-bis [ bi ( 2-ethoxyethyl ) phosphino ] ethane ) , Tc-99m sestamibi ( Tc-99m- methoxyisobutylisonitrile ) . When perform myocardial perfusion SPECT ( MPS ) study , extracardiac subdiaphragmatic activity adjacent myocardium cause artifacts inferior wall detrimental accuracy study1,2 . Following acquisition , MPS study routinely check potential imaging artifact . When separation extracardiac activity clearly distinguish myocardium , study repeat . Repeating SPECT study affect efficiency lab well negative influence patient comfort overall satisfaction . The goal study determine significant difference number study repeat two commonly used radiopharmaceutical .</detailed_description>
	<mesh_term>Ischemia</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Technetium Tc 99m 1,2-bis ( bis ( 2-ethoxyethyl ) phosphino ) ethane</mesh_term>
	<mesh_term>Technetium Tc 99m Sestamibi</mesh_term>
	<criteria>Patients receive sestamibi MPI study tetrofosmin MPI study Thallium dual isotope MPI study</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2009</verification_date>
	<keyword>Myocardial Perfusion Imaging</keyword>
	<keyword>Repeat study</keyword>
	<keyword>Tetrofosmin</keyword>
	<keyword>Sestamibi</keyword>
</DOC>